Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4542217016 | Relugolix-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4542218014 | Product containing relugolix (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Relugolix-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Relugolix-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Relugolix-containing product | Is a | Gonadotropin releasing hormone receptor antagonist-containing product | true | Inferred relationship | Some | ||
| Relugolix-containing product | Is a | Medicinal product categorised by structure | true | Inferred relationship | Some | ||
| Relugolix-containing product | Has active ingredient | Relugolix | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Relugolix only product | Is a | True | Relugolix-containing product | Inferred relationship | Some | |
| Relugolix-containing product in oral dose form | Is a | True | Relugolix-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR